Breaking

Israel hits Gaza hospital as strikes resume following hostage release
Relatives of El Chapo enter US as part of ‘negotiation,’ Mexico’s security secretary says
José Mujica, Uruguay’s modest leader who transformed the country, dies at 89
Israel targets Hamas leader Mohammed Sinwar in hospital strike in Gaza, sources say
Canada’s Carney unveils new cabinet with ‘primary focus’ on economy amid US tariffs
Former Olympic cyclist Rohan Dennis receives suspended sentence over wife’s death
Man wrongfully jailed for nearly four decades weeps as UK court overturns murder conviction
Exiled Bangladesh Prime Minister Sheikh Hasina’s party barred from election

Business
Politics
World
Investing
Search for:

Investing

First patient dosed in Phase IIb imaging for Brain Mets

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Microbial Mining? Endolith Makes Copper Recovery Breakthrough with Bioleaching Tech

Robinhood, WonderFi Deal Marks Bold C$250 Million Bet on Canada’s Crypto Future

3 Best-performing Canadian Rare Earth Stocks in 2025

Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (58)
- Investing (210)
- Politics (252)
- World (273)

Disclaimer: TimeFinances.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest

Copyright © 2025 TimeFinances.com | All Rights Reserved

Top

Business
Politics
World
Investing

Type above and press Enter to search. Press Esc to cancel.